Abstract
Child-BEAR-Net will create vital infrastructure to progress education, advocacy and research collaboration in paediatric bronchiectasis (see www.improveBE.org). With the ELF and parent advisory group, our initial planned projects respond to identified needs and complement the ERS paediatric bronchiectasis CPG [5]. Our CRC will advance bronchiectasis by raising awareness and encouraging an evidence-based approach to diagnosis and management. In doing so, this will improve the lives of the many children at risk of, or affected by, bronchiectasis.
Original language | English |
---|---|
Article number | 2101657 |
Pages (from-to) | 1-5 |
Number of pages | 5 |
Journal | European Respiratory Journal |
Volume | 58 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Oct 2021 |
Bibliographical note
Funding Information:Conflict of interest: A.B. Chang reports grants from National Health and Medical Research Council, Australia (NHMRC) during the conduct of the study; and that they are an independent data monitoring committee member for an unlicensed vaccine (GlaxoSmithKline), and advisory member of study design for unlicensed molecule for chronic cough (Merck), and an independent data monitoring committee member for a COVID-19 vaccine for children (Moderna), outside the submitted work. J. Boyd is an employee of the European Lung Foundation. A. Bush has nothing to disclose. K. Grimwood reports grants from National Health and Medical Research Council, Australia (NHMRC), during the conduct of the study. A.T. Hill has nothing to disclose. Z. Powell has nothing to declare. S. Yerkovich has nothing to disclose. A. Zacharasiewicz has nothing to disclose. A. Kantar has nothing to disclose.
Publisher Copyright:
© The authors 2021
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.